ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko01521	EGFR tyrosine kinase inhibitor resistance	4/37	106/7206	0.00201128323583
ko04012	ErbB signaling pathway	4/37	109/7206	0.00222785108593
ko05221	Acute myeloid leukemia	3/37	63/7206	0.00400431105587
ko04214	Apoptosis - fly	3/37	72/7206	0.00582656955986
ko04730	Long-term depression	3/37	78/7206	0.00727732865846
ko05205	Proteoglycans in cancer	5/37	271/7206	0.0117914259162
ko04720	Long-term potentiation	3/37	99/7206	0.0139393698628
ko05146	Amoebiasis	3/37	99/7206	0.0139393698628
ko04060	Cytokine-cytokine receptor interaction	4/37	191/7206	0.0159575756408
ko05219	Bladder cancer	2/37	48/7206	0.0249531211091
ko04011	MAPK signaling pathway - yeast	2/37	53/7206	0.0300003406587
ko04726	Serotonergic synapse	3/37	137/7206	0.0326314554654
ko05213	Endometrial cancer	2/37	62/7206	0.040004378404
ko05160	Hepatitis C	3/37	153/7206	0.0430949200744
ko04270	Vascular smooth muscle contraction	3/37	154/7206	0.043798982264
ko05223	Non-small cell lung cancer	2/37	66/7206	0.0448040321235
ko04020	Calcium signaling pathway	4/37	265/7206	0.0456287760305
ko04725	Cholinergic synapse	3/37	160/7206	0.0481452081747